Dietary Ca2+ is essential for the development and maintenance of bone
mineral mass. The vitamin D endocrine system plays a fundamental role
in the regulation of Ca2+ homeostasis, and mutations affecting genes i
mplicated in vitamin D metabolism or vitamin D receptor (VDR) function
s ave responsible for severe alterations in skeletal growth. In additi
on, vitamin D is also implicated in the pathophysiology and treatment
of adult bone disorders associated with impaired mineralization of bon
e matrix. Very recently, common polymorphisms in the 3'- and 5'-end re
gion oft he VDR gene have been suggested as possible determinants of b
one mineral mass and, hence of the risk of osteoporosis. None of these
polymorphisms appear to be associated unequivocally with bone mineral
mass or biochemical variables of Ca2+ and phosphate metabolism, excep
t perhaps VDR 3'-end polymorphisms before puberty. As these associatio
ns ave so inconsistent, interactions with environmental factors, parti
cularly dietary intake, and with other polymorphisms have to be consid
ered.